Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by LTOWNERon Jun 13, 2014 1:54pm
224 Views
Post# 22658396

RE:RE:RE:Pondering the Placebo...

RE:RE:RE:Pondering the Placebo...Yes they are meeting with the FDA in the next couple of months to get Natesto BID approved.  BID had 70% efficacy in the P3 - makes sense for men to start on BID, but the FDA was blown away by 92% efficacy in the TID.  The FDA has to agree on the titration from BID to TID for the other 30%.  Very doable.  However in the trial the men were almost as happy using the TID as the BID.  A minor inconvenience if they feel so much better on TRT, plus it takes seconds to apply, no transference etc.  But since you sold all your stock yesterday I'm not sure you are really interested.  I was there yesterday and there was no rush for the door after a very long meeting.  
Bullboard Posts